Number of the records: 1
Expression of RAN, ZHX-2, and CHC1L genes in multiple myeloma patients and in myeloma cell lines treated with HDAC and Dnmts inhibitors
- 1.
SYSNO ASEP 0347297 Document Type J - Journal Article R&D Document Type Journal Article Subsidiary J Článek ve WOS Title Expression of RAN, ZHX-2, and CHC1L genes in multiple myeloma patients and in myeloma cell lines treated with HDAC and Dnmts inhibitors Author(s) Legartová, Soňa (BFU-R) ORCID
Harničarová, Andrea (BFU-R) ORCID
Bártová, Eva (BFU-R) ORCID
Hájek, R. (CZ)
Pour, L. (CZ)
Kozubek, Stanislav (BFU-R) RIDNumber of authors 6 Source Title Neoplasma - ISSN 0028-2685
Roč. 57, č. 5 (2010), s. 482-487Number of pages 6 s. Language eng - English Country SK - Slovakia Keywords multiple myeloma ; RAN ; ZHX-2 Subject RIV BO - Biophysics R&D Projects ME 919 GA MŠMT - Ministry of Education, Youth and Sports (MEYS) GAP302/10/1022 GA ČR - Czech Science Foundation (CSF) CEZ AV0Z50040507 - BFU-R (2005-2011) AV0Z50040702 - BFU-R (2007-2013) UT WOS 000283760800013 DOI 10.4149/neo_2010_05_482 Annotation In myeloma patients we observed significant changes in the expression of RAN, ZHX-2, and CHC1L genes, but it was patient-specific. Our experiments illustrate new methodological approaches and troubleshooting for conducting gene expression studies with clinical samples. Workplace Institute of Biophysics Contact Jana Poláková, polakova@ibp.cz, Tel.: 541 517 244 Year of Publishing 2011
Number of the records: 1